Page last updated: 2024-09-05

me 3221 and saralasin

me 3221 has been researched along with saralasin in 1 studies

Compound Research Comparison

Studies
(me 3221)
Trials
(me 3221)
Recent Studies (post-2010)
(me 3221)
Studies
(saralasin)
Trials
(saralasin)
Recent Studies (post-2010) (saralasin)
7001,4971316

Protein Interaction Comparison

ProteinTaxonomyme 3221 (IC50)saralasin (IC50)
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.0017
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0017
Type-1 angiotensin II receptorHomo sapiens (human)0.0006
Type-2 angiotensin II receptorHomo sapiens (human)0.0008

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujishima, K; Hachisu, M; Kawano, K; Konno, F; Nagura, J; Yasuda, S1

Other Studies

1 other study(ies) available for me 3221 and saralasin

ArticleYear
Nonpeptide angiotensin II receptor antagonist recognizes inter-species differences in angiotensin AT1 receptors.
    European journal of pharmacology, 1998, Sep-11, Volume: 357, Issue:1

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Brain; Cattle; Cell Membrane; Dithiothreitol; Dogs; Female; Liver; Male; Muscle, Smooth, Vascular; Pressoreceptors; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Saralasin; Species Specificity; Sulfhydryl Reagents; Tetrazoles

1998